Alexander Herbst, MD
Dermatology · Port Charlotte, FLNPI 1437680949
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Pfizer at 57.8% of the total. Reporting peaked in 2021 at $2,959 and has fallen 88.2% since, to $350 in 2025.
Across 88 payments — averaging $56.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- AbbVie$634
- Regeneron Healthcare Solutions, Inc.$311
- Johnson & Johnson$303
- Organogenesis Inc.$146
- Sanofi$99
- plus $619 from 12 others
What the payments were for
- Speaking & faculty fees$2,70054%
- Food & beverage$2,21244%
- Education$992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $2,898 |
| AbbVie(2 entities) | 18 | $634 |
| Regeneron Healthcare Solutions, Inc. | 13 | $311 |
| Johnson & Johnson | 11 | $303 |
| Organogenesis Inc. | 6 | $146 |
| Sanofi | 4 | $99 |
| Galderma Laboratories, L.p. | 5 | $95 |
| Amgen | 4 | $83 |
| Elekta, Inc. | 2 | $77 |
| Sun Pharmaceutical Industries Inc. | 3 | $66 |
| Biofrontera Inc. | 3 | $63 |
| Novartis | 3 | $54 |
| Lilly USA, LLC | 2 | $47 |
| Kerecis Limited | 3 | $42 |
| LEO Pharma Inc. | 1 | $32 |
| Almirall LLC | 1 | $28 |
| Mimedx Group, Inc. | 1 | $19 |
| Strata Skin Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$281
- EUCRISA$107
How this compares
$5,011 in reported general payments places this provider in the 65th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 24 | $95,631 |
| Clobetasol Propionate | 60 | $2,427 |
| Ketoconazole | 95 | $1,731 |
| Gentamicin Sulfate | 31 | $1,158 |
| Fluorouracil | 13 | $915 |
| Mometasone Furoate | 55 | $861 |
| Doxycycline Hyclate | 34 | $796 |
| Triamcinolone Acetonide | 51 | $761 |
| Fluocinonide | 15 | $606 |
| Mupirocin | 76 | $577 |
| MethotrexateMethotrexate Sodium | 23 | $471 |
| Betamethasone Dipropionate | 14 | $446 |
| Alclometasone Dipropionate | 11 | $377 |
| Clindamycin Phosphate | 23 | $342 |
| Cephalexin | 60 | $325 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Port Charlotte
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.